Last reviewed · How we verify
NCT03678571
Oocyte Vitrification Aided With Latrunculin A
NA trial testing Latrunculin A supplemented vitrification medium in Infertility in 400 participants. Completed in 15 July 2019.
1 July 2019
Quick facts
| Lead sponsor | Ibn Sina Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 400 |
| Start date | 25 September 2018 |
| Primary completion | 1 July 2019 |
| Estimated completion | 15 July 2019 |
| Sites | 3 locations across Egypt |
Drugs / interventions tested
- Latrunculin A supplemented vitrification medium
Conditions studied
- Infertility — all drugs for Infertility →
Sponsor
Ibn Sina Hospital
Who can join
Adults 18 to 42, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Using cytoskeleton Stabilizer the Latrunculin A would improve the outcome of oocyte vitrification
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03678571
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other Ibn Sina Hospital trials
Trials by the same sponsor.
- NCT02896777 — Triple-arm pH Comparison · NA · completed
- NCT06503835 — Efficacy of Transforaminal Epidural Steroid and Its Combination With Ozone in Lumbar Radiculopathy · completed
- NCT04210414 — Cleave-stage Transfer on Day 3 Versus Day 5 Transfer When Only One Embryo Available · NA · terminated
- NCT04052607 — Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol for Freeze-all Cycles · NA · terminated
- NCT03823235 — Humidified Culture and Live Birth After ICSI · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03678571 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ibn Sina Hospital
- Last refreshed: 16 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03678571.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing